Uncategorized
Summit Therapeutics’ Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences
Summit’s ivonescimab showed improved survival trends in NSCLC patients with favorable safety, though some results missed statistical significance thresholds. read more
How To Earn $500 A Month From Designer Brands Stock Ahead Of Q2 Earnings
Designer Brands currently offers an annual dividend yield of 4.23% — 20 cents a year. Here’s how you can earn $500 monthly. read more
Jim Cramer Urges Caution On Intel Rally, Says IBM Offers More Than D-Wave
Jim Cramer recommends Elbit Systems (ESLT) and Preformed Line Products (PLPC). Intel (INTC) and Gray Media (GTN) are also discussed. read more
Beth Kindig Warns Of AI Software ‘Bubble’ Risk Amid R&D Stage, Says True Value Lies In Stocks That Are ‘Participating Right Now’
I/O Fund’s Beth Kindig warns of an AI bubble in software stocks still in the R&D stage and explains where investors can find real value now. read more
Trump’s Tariffs ‘Bite’ China As Trade With US Sees ‘Substantial Contraction,’ El-Erian Warns Of ‘Significant Challenges’ To Xi Jinping’s Growth Plan
Economist Mohamed El-Erian warns of “significant challenges” for China as U.S. tariffs trigger a “substantial contraction” in trade. read more